Why the study?
Does initiating or continuing perioperative beta-blockade improve outcomes and offer protection against cardiac events in patients presenting for surgery?
Does initiating or continuing perioperative beta-blockade improve outcomes and offer protection against cardiac events in patients presenting for surgery?
Routine initiation or continuation of perioperative beta-blockade without further clinical assessment is not supported by current data.
Clinicians should avoid routine perioperative beta-blockade without assessment; leaves open its role pending targeted prospective trials.
The use of beta-blockers in the management of patients with coronary artery disease, arterial hypertension and cardiac failure suggests that they should offer significant protection against perioperative cardiac events. Initiating or continuing beta-blockade in patients presenting for surgery may be regarded as offering protection with no need for further assessment of investigations. However, data do not support this and appropriate investigations are needed.
No takes yet. Share an insight, caveat, or question.
Pierre Foë (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: